Role of RBC-TLR9 in Acute Inflammatory Anemia

RBC-TLR9 在急性炎症性贫血中的作用

基本信息

  • 批准号:
    10352593
  • 负责人:
  • 金额:
    $ 24.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-05 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

Project Abstract/Summary: The global burden of anemia is high, with a worldwide prevalence of 25%. Anemia is a hallmark of infectious diseases, including parasite infection, and is often lethal in developing countries, with life-threatening malarial anemia affecting predominantly babies and toddlers. In other parts of the world, anemia is highly prevalent in critically ill patients, with almost all patients developing anemia during their ICU stay. In this population, RBC transfusions are associated with increased morbidity and mortality. A mechanistic understanding of the acute anemia characterizing infection and critical illness is urgently needed given the high morbidity and mortality and potential harm of transfusions in select populations. One fundamental and critical knowledge gap is a lack of understanding of how red blood cells (RBCs) contribute to the innate immune response and inflammatory anemia. Whether RBCs are passive bystanders or actively contribute to the development of acute inflammatory anemia is unknown. DNA-sensing is an essential component of the innate immune response to infection and sterile injury, and nucleic acid sensing-TLRs in phagocytes are implicated in developing inflammatory anemia, which is frequently observed during bacterial sepsis and parasitic infections. We have recently found that RBCs express the nucleic acid receptor TLR9 and bind cell-free CpG-containing DNA. During inflammatory states, RBCs capture DNA from the circulation and undergo morphologic changes and accelerated senescence. Our preliminary data demonstrate that RBC, not phagocyte, TLR9 drives accelerated erythrophagocytosis. Because elevated cell-free CpG-DNA and acute anemia are features common to sepsis, parasite infection, and sterile inflammation, we hypothesize that nucleic acid capture by RBC-TLR9 and consequent erythrophagocytosis represents a universal mechanism of acute inflammatory anemia. Based upon this hypothesis, we will address two aims using human erythroid-derived progenitor cells, genetically deficient mice, and in vivo models of parasite infection, sepsis, anemia, and sterile inflammation. In aim 1, we will determine if CpG-induced RBC senescence is dependent on RBC-TLR9. In aim 2, we will evaluate the erythroid-specific role of TLR9 in driving inflammatory anemia in vivo. We will ask if RBC-DNA binding is sufficient to cause anemia and whether RBC clearance is dependent on erythrocyte TLR9. We will also determine the lineage-specific functions of RBC-TLR9 in the development of anemia during infection and sterile inflammation using a combination of genetically deficient mice and RBC transfer models. While exploratory in nature, discovering a universal nucleic acid-sensing mechanism by red cells may elucidate critical determinants of inflammatory anemia, and completion of the proposed aims may provide insight into novel therapeutics for this highly prevalent disease.
项目摘要/摘要:全球贫血负担高,全球患病率为25%。贫血

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nilam S. Mangalmurti其他文献

Neutrophil Extracellular Traps (NETs) Thrombogenicity and Endothelial Cell Toxicity Are Ameliorated By Platelet Factor 4 (PF4): Implications to the Treatment of Sepsis
  • DOI:
    10.1182/blood-2022-169709
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Anh T.P. Ngo;Amrita Sarkar;Nathan Levine;Veronica Bochenek;Guohua Zhao;Lubica Rauova;M. Anna Kowalska;Kaitlyn Eckart;Nilam S. Mangalmurti;Ann Rux;Douglas B. Cines;Mortimer Poncz;Kandace Gollomp
  • 通讯作者:
    Kandace Gollomp

Nilam S. Mangalmurti的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nilam S. Mangalmurti', 18)}}的其他基金

Role of RBC-TLR9 in Acute Inflammatory Anemia
RBC-TLR9 在急性炎症性贫血中的作用
  • 批准号:
    10618182
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE and Necroptosis in Transfusion Mediated Lung Inflammation
RAGE 和坏死性凋亡在输血介导的肺部炎症中的作用
  • 批准号:
    9195143
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE and Necroptosis in Transfusion Mediated Lung Inflammation
RAGE 和坏死性凋亡在输血介导的肺部炎症中的作用
  • 批准号:
    9028744
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE in Transfusion Mediated Acute Lung Injury
RAGE 在输血介导的急性肺损伤中的作用
  • 批准号:
    7770428
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE in Transfusion Mediated Acute Lung Injury
RAGE 在输血介导的急性肺损伤中的作用
  • 批准号:
    8240473
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE in Transfusion Mediated Acute Lung Injury
RAGE 在输血介导的急性肺损伤中的作用
  • 批准号:
    8445418
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE in Transfusion Mediated Acute Lung Injury
RAGE 在输血介导的急性肺损伤中的作用
  • 批准号:
    8048105
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Role of RAGE in Transfusion Mediated Acute Lung Injury
RAGE 在输血介导的急性肺损伤中的作用
  • 批准号:
    8651935
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Erythrocyte Transfusion in Acute Lung Injury During Sepsis
脓毒症期间急性肺损伤的红细胞输注
  • 批准号:
    7406981
  • 财政年份:
    2008
  • 资助金额:
    $ 24.38万
  • 项目类别:
Erythrocyte Transfusion in Acute Lung Injury During Sepsis
脓毒症期间急性肺损伤的红细胞输注
  • 批准号:
    7673538
  • 财政年份:
    2008
  • 资助金额:
    $ 24.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了